Literature DB >> 28826533

Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events.

Colin Davidson1, Jolanta Opacka-Juffry2, Angel Arevalo-Martin3, Daniel Garcia-Ovejero3, Eduardo Molina-Holgado3, Francisco Molina-Holgado4.   

Abstract

Recreational use of synthetic cannabinoids (SCB), a class of novel psychoactive substances is an increasing public health problem specifically in Western societies, with teenagers, young adults, and the prison population being the most affected. Some of these SCB are analogs of tetrahydrocannabinol, aminoalkylindoles, and other phytocannabinoid analogs have been detected in herbal preparations generically called "Spice." Spice, "K2" or "fake cannabis" is a general term used for variable herbal mixtures of unknown ingredients or chemical composition. SCB are highly potent CB1 cannabinoid receptor agonists falsely marketed and sold as safe and legal drugs. Here, we present an overview of the endocannabinoid system, CB, and SCB chemical structures and activity at CB receptors. Finally, we highlight the psychological effects of SCB, particularly on learning and memory, and adverse clinical effects including on the cardiovascular system, kidneys, and CNS, including psychosis. Taken together, it is clear that many SCB are extremely dangerous and a major public health problem.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Addiction; Cannabinoid receptors; Designer drugs; Novel psychoactive substances; Psychosis; Synthetic cannabinoids

Mesh:

Substances:

Year:  2017        PMID: 28826533     DOI: 10.1016/bs.apha.2017.05.001

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


  15 in total

1.  Positive Allosteric Modulation of the 5-HT1A Receptor by Indole-Based Synthetic Cannabinoids Abused by Humans.

Authors:  Hideaki Yano; Pramisha Adhikari; Sett Naing; Alexander F Hoffman; Michael H Baumann; Carl R Lupica; Lei Shi
Journal:  ACS Chem Neurosci       Date:  2020-04-30       Impact factor: 4.418

2.  Cannabinoid-like effects of five novel carboxamide synthetic cannabinoids.

Authors:  Michael B Gatch; Michael J Forster
Journal:  Neurotoxicology       Date:  2018-11-12       Impact factor: 4.294

Review 3.  How preclinical studies have influenced novel psychoactive substance legislation in the UK and Europe.

Authors:  Raquel Santos-Toscano; Amira Guirguis; Colin Davidson
Journal:  Br J Clin Pharmacol       Date:  2020-02-23       Impact factor: 4.335

Review 4.  The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective.

Authors:  Laura Orsolini; Stefania Chiappini; Duccio Papanti; Domenico De Berardis; John M Corkery; Fabrizio Schifano
Journal:  Front Psychiatry       Date:  2019-11-20       Impact factor: 4.157

Review 5.  Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids.

Authors:  Dennis J Sholler; Marilyn A Huestis; Benjamin Amendolara; Ryan Vandrey; Ziva D Cooper
Journal:  Pharmacol Biochem Behav       Date:  2020-10-18       Impact factor: 3.533

6.  Broad and Region-Specific Impacts of the Synthetic Cannabinoid CP 55,940 in Adolescent and Adult Female Mouse Brains.

Authors:  Emma Leishman; Michelle N Murphy; Michelle I Murphy; Ken Mackie; Heather B Bradshaw
Journal:  Front Mol Neurosci       Date:  2018-11-27       Impact factor: 5.639

Review 7.  Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps.

Authors:  Cristina Miliano; Giulia Margiani; Liana Fattore; Maria Antonietta De Luca
Journal:  Brain Sci       Date:  2018-06-29

Review 8.  Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective.

Authors:  Koby Cohen; Aviv M Weinstein
Journal:  Front Public Health       Date:  2018-06-07

9.  In Vitro Neurochemical Assessment of Methylphenidate and Its "Legal High" Analogs 3,4-CTMP and Ethylphenidate in Rat Nucleus Accumbens and Bed Nucleus of the Stria Terminalis.

Authors:  Colin Davidson; Christopher A R Raby; Vincenzo Barrese; John Ramsey
Journal:  Front Psychiatry       Date:  2018-05-28       Impact factor: 4.157

10.  Pharmacological evaluation of new constituents of "Spice": synthetic cannabinoids based on indole, indazole, benzimidazole and carbazole scaffolds.

Authors:  Clara T Schoeder; Cornelius Hess; Burkhard Madea; Jens Meiler; Christa E Müller
Journal:  Forensic Toxicol       Date:  2018-04-26       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.